Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors.
Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., Hilgenfeld, R.(2020) Science 368: 409-412
- PubMed: 32198291 
- DOI: https://doi.org/10.1126/science.abb3405
- Primary Citation of Related Structures:  
6Y2E, 6Y2F, 6Y2G, 6Y7M - PubMed Abstract: 
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is a global health emergency. An attractive drug target among coronaviruses is the main protease (M pro , also called 3CL pro ) because of its essential role in processing the polyproteins that are translated from the viral RNA ...